Jacqueline Ndirangu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacqueline Ndirangu has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Wendee M. Wechsberg
RTI International
10 shared publications - Felicia A. Browne
Senior Research Social Epidemiologist RTI International
8 shared publications - Alexandra M. Minnis
RTI International
6 shared publications - Brittni N. Howard
Public Health Analyst III RTI International
5 shared publications - Courtney Peasant Bonner
RTI International, Research Triangle Park, USA
4 shared publications - Tracy L. Kline
RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
4 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- p. 1-28
Evaluating the effects of a multi-level intervention on young women’s contraceptive use: sexual and reproductive health results of a cluster-randomized factorial-design study in Tshwane, South Africa
In South Africa, adolescent girls and young women (AGYW) are engaged in early, condomless, and unprotected (from pregnancy) sex, which puts them at risk of unintended pregnancies and sexually transmitted infections. At the individual, interpersonal, and structural levels, AGYW experience barriers to their access to and use of contraception and condoms. This study employed a cluster-randomised factorial design to examine the impact of a multi-level intervention on contraceptive use behaviours among 802 women ages 16-24 in Tshwane, South Africa. The two intervention components were the Young Women's Health CoOp (YWHC), an intervention to increase participants' knowledge and skills, and a stigma and discrimination (S&D) reduction training at the facility level. Study facilities were randomised into the four study arms: YWHC only; S&D only; both YWHC and S&D; and control (standard of care). The study demonstrated that AGYW in the YWHC arm (RRR: 2.45; 95% CI: 1.05-5.70, p = 0.038) and those in the YWHC and S&D arm (RRR: 3.65; 95%CI: 1.56-8.50, p = 0.003) were more likely to have started a contraceptive method than to remain a non-user compared to those in the control arm over the 9-month follow-up period. However, those in the S&D training-only arm had lower odds of adopting a method over the follow-up period (OR: 0.63; 95% CI: 0.41-0.97, p = 0.037). These results demonstrate the importance of supporting AGYW with tailored messaging in a safe environment as part of sexual and reproductive health services.
- 1 July 2026
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- p. 1-28
Open AccessEvaluating the effects of a multi-level intervention on young women’s contraceptive use: sexual and reproductive health results of a cluster-randomized factorial-design study in Tshwane, South Africa
In South Africa, adolescent girls and young women (AGYW) are engaged in early, condomless, and unprotected (from pregnancy) sex, which puts them at risk of unintended pregnancies and sexually transmitted infections. At the individual, interpersonal, and structural levels, AGYW experience barriers to their access to and use of contraception and condoms. This study employed a cluster-randomised factorial design to examine the impact of a multi-level intervention on contraceptive use behaviours among 802 women ages 16-24 in Tshwane, South Africa. The two intervention components were the Young Women's Health CoOp (YWHC), an intervention to increase participants' knowledge and skills, and a stigma and discrimination (S&D) reduction training at the facility level. Study facilities were randomised into the four study arms: YWHC only; S&D only; both YWHC and S&D; and control (standard of care). The study demonstrated that AGYW in the YWHC arm (RRR: 2.45; 95% CI: 1.05-5.70, p = 0.038) and those in the YWHC and S&D arm (RRR: 3.65; 95%CI: 1.56-8.50, p = 0.003) were more likely to have started a contraceptive method than to remain a non-user compared to those in the control arm over the 9-month follow-up period. However, those in the S&D training-only arm had lower odds of adopting a method over the follow-up period (OR: 0.63; 95% CI: 0.41-0.97, p = 0.037). These results demonstrate the importance of supporting AGYW with tailored messaging in a safe environment as part of sexual and reproductive health services.
- Open Access
- 14 October 2025
- Published by Springer Nature in Reproductive Health
- Vol. 22 (1) , 1-8
I needed somebody to encourage me to take it [PrEP], maybe it would have protected me and the baby: a qualitative study to understand prenatal oral PrEP use among pregnant adolescent girls and young women in Tshwane, South Africa
South Africa has the highest number of people living with HIV globally, with adolescent girls and young women (AGYW) being disproportionately affected. Pregnant AGYW are particularly vulnerable to HIV due to hormonal changes, leading to increased risks of HIV transmission, including mother-to-child transmission. Pre-exposure prophylaxis (PrEP) is recommended to prevent HIV in this population, but concerns and lack of knowledge about its safety hinder uptake and continuation during pregnancy. This qualitative sub-study was part of a cluster-randomized controlled trial in Tshwane, South Africa, involving 12 public health clinics. The parent study aimed to enroll AGYW aged 16–24 who were HIV-negative, reported to have had condomless sex, and were interested in taking PrEP. For this sub-study, 25 AGYW who became pregnant after enrollment were invited, and 16 consented to participate in in-depth interviews. Journey mapping was used to explore participants’ experiences with PrEP before and during pregnancy. Interviews were conducted in English, Sesotho, and Setswana, then transcribed and coded for analysis. Inter-coder reliability reached a Krippendorff Cu-Alpha score of 0.84. The journey maps were combined and depicted graphically to understand the AGYW PrEP use journey during pregnancy. Most AGYW discontinued PrEP upon discovering their pregnancy due to concerns about potential risks to the unborn baby despite evidence showing PrEP is safe during pregnancy and breastfeeding. Participants experienced common PrEP side effects such as nausea, which they found difficult to distinguish from pregnancy-related symptoms. Lack of support from healthcare providers and family members further contributed to their decision to stop PrEP. Clinicians, often unfamiliar with updated guidelines recommending PrEP for pregnant women, advised discontinuation. AGYW expressed a need for greater support and reassurance from both healthcare providers and their families. Despite the safety of oral PrEP during pregnancy, AGYW in South Africa lack the necessary information and support to continue its use. Empowering healthcare providers and family members to offer informed guidance and reassurance, AGYW may gain the confidence needed to make critical HIV prevention decisions during pregnancy. Targeted strategies, such as provider training with community PrEP education, are essential to protect pregnant AGYW’s well-being and reduce their HIV risk.
- 14 October 2025
- Published by Springer Nature in Reproductive Health
- Vol. 22 (1) , 1-8
Open AccessI needed somebody to encourage me to take it [PrEP], maybe it would have protected me and the baby: a qualitative study to understand prenatal oral PrEP use among pregnant adolescent girls and young women in Tshwane, South Africa
South Africa has the highest number of people living with HIV globally, with adolescent girls and young women (AGYW) being disproportionately affected. Pregnant AGYW are particularly vulnerable to HIV due to hormonal changes, leading to increased risks of HIV transmission, including mother-to-child transmission. Pre-exposure prophylaxis (PrEP) is recommended to prevent HIV in this population, but concerns and lack of knowledge about its safety hinder uptake and continuation during pregnancy. This qualitative sub-study was part of a cluster-randomized controlled trial in Tshwane, South Africa, involving 12 public health clinics. The parent study aimed to enroll AGYW aged 16–24 who were HIV-negative, reported to have had condomless sex, and were interested in taking PrEP. For this sub-study, 25 AGYW who became pregnant after enrollment were invited, and 16 consented to participate in in-depth interviews. Journey mapping was used to explore participants’ experiences with PrEP before and during pregnancy. Interviews were conducted in English, Sesotho, and Setswana, then transcribed and coded for analysis. Inter-coder reliability reached a Krippendorff Cu-Alpha score of 0.84. The journey maps were combined and depicted graphically to understand the AGYW PrEP use journey during pregnancy. Most AGYW discontinued PrEP upon discovering their pregnancy due to concerns about potential risks to the unborn baby despite evidence showing PrEP is safe during pregnancy and breastfeeding. Participants experienced common PrEP side effects such as nausea, which they found difficult to distinguish from pregnancy-related symptoms. Lack of support from healthcare providers and family members further contributed to their decision to stop PrEP. Clinicians, often unfamiliar with updated guidelines recommending PrEP for pregnant women, advised discontinuation. AGYW expressed a need for greater support and reassurance from both healthcare providers and their families. Despite the safety of oral PrEP during pregnancy, AGYW in South Africa lack the necessary information and support to continue its use. Empowering healthcare providers and family members to offer informed guidance and reassurance, AGYW may gain the confidence needed to make critical HIV prevention decisions during pregnancy. Targeted strategies, such as provider training with community PrEP education, are essential to protect pregnant AGYW’s well-being and reduce their HIV risk.
- 14 April 2025
- Published by Oxford University Press (OUP) in Health Education Research
- Vol. 40 (3)
‘Those sessions open[ed] our eyes and our minds’: participant acceptability and satisfaction with a gender-focused HIV and substance use risk-reduction intervention on alcohol use, HIV treatment, and sexual behaviour among women in South Africa
Women living with human immunodeficiency virus (HIV) who use alcohol are at a heightened risk of disengagement in HIV care. A mixed-methods substudy was embedded in an implementation science trial to assess perceived satisfaction and acceptability of the Women’s Health CoOp (WHC), a gender-focused, alcohol and harmful substance use, HIV biobehavioural intervention in Cape Town, South Africa. A modified version of the Client Satisfaction Questionnaire (CSQ-8)® was used to assess patient satisfaction (N = 456). Eight focus groups were also conducted to assess the perceived acceptability and satisfaction of the WHC after completion of the intervention workshops. Participants reported being very pleased with the WHC with an acceptable internal consistency estimate (α = .81). Intervention satisfaction was high (M = 30.9; SD = 0.1) on the CSQ-8 scale. Focus group participants reported that the WHC helped them reduce the amount and frequency of heavy alcohol use. Knowledge gained through the WHC reduced misperceptions about mixing alcohol with antiretroviral therapy and motivated re-engagement in HIV care. Participants also reported a decrease in condomless sex. Interventions that support and empower women living with HIV reporting heavy alcohol use should be implemented sustainably to improve HIV treatment retention and re-engagement and to reduce alcohol consumption among this population.
- 14 April 2025
- Published by Oxford University Press (OUP) in Health Education Research
- Vol. 40 (3)
‘Those sessions open[ed] our eyes and our minds’: participant acceptability and satisfaction with a gender-focused HIV and substance use risk-reduction intervention on alcohol use, HIV treatment, and sexual behaviour among women in South Africa
Women living with human immunodeficiency virus (HIV) who use alcohol are at a heightened risk of disengagement in HIV care. A mixed-methods substudy was embedded in an implementation science trial to assess perceived satisfaction and acceptability of the Women’s Health CoOp (WHC), a gender-focused, alcohol and harmful substance use, HIV biobehavioural intervention in Cape Town, South Africa. A modified version of the Client Satisfaction Questionnaire (CSQ-8)® was used to assess patient satisfaction (N = 456). Eight focus groups were also conducted to assess the perceived acceptability and satisfaction of the WHC after completion of the intervention workshops. Participants reported being very pleased with the WHC with an acceptable internal consistency estimate (α = .81). Intervention satisfaction was high (M = 30.9; SD = 0.1) on the CSQ-8 scale. Focus group participants reported that the WHC helped them reduce the amount and frequency of heavy alcohol use. Knowledge gained through the WHC reduced misperceptions about mixing alcohol with antiretroviral therapy and motivated re-engagement in HIV care. Participants also reported a decrease in condomless sex. Interventions that support and empower women living with HIV reporting heavy alcohol use should be implemented sustainably to improve HIV treatment retention and re-engagement and to reduce alcohol consumption among this population.
- Open Access
- 1 April 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e55931
Evaluation of the Tu’Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial
Background: Adolescent girls and young women constitute a priority population disproportionately affected by HIV, accounting for 25% of annual HIV incidence among people older than 15 years in Kenya. Although oral preexposure prophylaxis (PrEP) is effective in reducing HIV acquisition, its protective benefit has been limited among adolescent girls and young women in sub-Saharan Africa because of low uptake, adherence, and persistence. Intimate partner violence (IPV) and relationship power inequities are widespread among adolescent girls and young women and contribute to higher HIV incidence and lower PrEP use. Interventions are needed to support sustained PrEP use among adolescent girls and young women by addressing IPV and relationship dynamics. Objective: This study aims to test the effectiveness of Tu’Washindi na PrEP (“We are Winners with PrEP”), a multilevel community-based intervention, to increase uptake and adherence to PrEP and reduce IPV among adolescent girls and young women in Siaya County, Kenya. Methods: The Tu’Washindi na PrEP intervention was co-designed by our team and adolescent girls and young women using participatory methods and includes 3 components delivered over 6 months: an 8-session, empowerment-based support club for adolescent girls and young women, community sensitization targeted toward male partners, and PrEP education events for couples. The intervention will be evaluated using a cluster randomized controlled trial across 22 administrative wards in Siaya County, Kenya, enrolling 72 adolescent girls and young women per ward (total N=1584). The primary objectives are to test the effectiveness of the intervention on PrEP uptake and adherence immediately after delivery (month 6 after enrollment) and 6 months later (month 12). As secondary objectives, we will test the intervention effect on IPV. A rigorous process evaluation will explore mechanisms of change, contextual factors, and implementation considerations to inform future refinement and scale-up, using programmatic data, participant questionnaires, and qualitative interviews with participants and intervention providers. Results: Data collection started in September 2022. As of December 2024, enrollment has been completed in 16 of the 22 study wards, with 72.6% (1150/1584) of participants enrolled. We anticipate that data collection will be completed in May 2026 and results will be available by mid-2027. Conclusions: The study builds directly on our promising formative and pilot research to develop the evidence base for this youth-designed, multilevel HIV prevention intervention. If effective, Tu’Washindi will be ideally positioned for sustainable integration into existing youth-focused programming to expand and support PrEP use in this priority population. Trial Registration: ClinicalTrials.gov NCT05599581; https://www.clinicaltrials.gov/study/NCT05599581 International Registered Report Identifier (IRRID): DERR1-10.2196/55931
- 1 April 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e55931
Open AccessEvaluation of the Tu’Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial
Background: Adolescent girls and young women constitute a priority population disproportionately affected by HIV, accounting for 25% of annual HIV incidence among people older than 15 years in Kenya. Although oral preexposure prophylaxis (PrEP) is effective in reducing HIV acquisition, its protective benefit has been limited among adolescent girls and young women in sub-Saharan Africa because of low uptake, adherence, and persistence. Intimate partner violence (IPV) and relationship power inequities are widespread among adolescent girls and young women and contribute to higher HIV incidence and lower PrEP use. Interventions are needed to support sustained PrEP use among adolescent girls and young women by addressing IPV and relationship dynamics. Objective: This study aims to test the effectiveness of Tu’Washindi na PrEP (“We are Winners with PrEP”), a multilevel community-based intervention, to increase uptake and adherence to PrEP and reduce IPV among adolescent girls and young women in Siaya County, Kenya. Methods: The Tu’Washindi na PrEP intervention was co-designed by our team and adolescent girls and young women using participatory methods and includes 3 components delivered over 6 months: an 8-session, empowerment-based support club for adolescent girls and young women, community sensitization targeted toward male partners, and PrEP education events for couples. The intervention will be evaluated using a cluster randomized controlled trial across 22 administrative wards in Siaya County, Kenya, enrolling 72 adolescent girls and young women per ward (total N=1584). The primary objectives are to test the effectiveness of the intervention on PrEP uptake and adherence immediately after delivery (month 6 after enrollment) and 6 months later (month 12). As secondary objectives, we will test the intervention effect on IPV. A rigorous process evaluation will explore mechanisms of change, contextual factors, and implementation considerations to inform future refinement and scale-up, using programmatic data, participant questionnaires, and qualitative interviews with participants and intervention providers. Results: Data collection started in September 2022. As of December 2024, enrollment has been completed in 16 of the 22 study wards, with 72.6% (1150/1584) of participants enrolled. We anticipate that data collection will be completed in May 2026 and results will be available by mid-2027. Conclusions: The study builds directly on our promising formative and pilot research to develop the evidence base for this youth-designed, multilevel HIV prevention intervention. If effective, Tu’Washindi will be ideally positioned for sustainable integration into existing youth-focused programming to expand and support PrEP use in this priority population. Trial Registration: ClinicalTrials.gov NCT05599581; https://www.clinicaltrials.gov/study/NCT05599581 International Registered Report Identifier (IRRID): DERR1-10.2196/55931
- Open Access
- 30 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluation of the Tu’Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial (Preprint)
BACKGROUND Adolescent girls and young women constitute a priority population disproportionately affected by HIV, accounting for 25% of annual HIV incidence among people older than 15 years in Kenya. Although oral preexposure prophylaxis (PrEP) is effective in reducing HIV acquisition, its protective benefit has been limited among adolescent girls and young women in sub-Saharan Africa because of low uptake, adherence, and persistence. Intimate partner violence (IPV) and relationship power inequities are widespread among adolescent girls and young women and contribute to higher HIV incidence and lower PrEP use. Interventions are needed to support sustained PrEP use among adolescent girls and young women by addressing IPV and relationship dynamics. OBJECTIVE This study aims to test the effectiveness of Tu’Washindi na PrEP (“We are Winners with PrEP”), a multilevel community-based intervention, to increase uptake and adherence to PrEP and reduce IPV among adolescent girls and young women in Siaya County, Kenya. METHODS The Tu’Washindi na PrEP intervention was co-designed by our team and adolescent girls and young women using participatory methods and includes 3 components delivered over 6 months: an 8-session, empowerment-based support club for adolescent girls and young women, community sensitization targeted toward male partners, and PrEP education events for couples. The intervention will be evaluated using a cluster randomized controlled trial across 22 administrative wards in Siaya County, Kenya, enrolling 72 adolescent girls and young women per ward (total N=1584). The primary objectives are to test the effectiveness of the intervention on PrEP uptake and adherence immediately after delivery (month 6 after enrollment) and 6 months later (month 12). As secondary objectives, we will test the intervention effect on IPV. A rigorous process evaluation will explore mechanisms of change, contextual factors, and implementation considerations to inform future refinement and scale-up, using programmatic data, participant questionnaires, and qualitative interviews with participants and intervention providers. RESULTS Data collection started in September 2022. As of December 2024, enrollment has been completed in 16 of the 22 study wards, with 72.6% (1150/1584) of participants enrolled. We anticipate that data collection will be completed in May 2026 and results will be available by mid-2027. CONCLUSIONS The study builds directly on our promising formative and pilot research to develop the evidence base for this youth-designed, multilevel HIV prevention intervention. If effective, Tu’Washindi will be ideally positioned for sustainable integration into existing youth-focused programming to expand and support PrEP use in this priority population. CLINICALTRIAL ClinicalTrials.gov NCT05599581; https://www.clinicaltrials.gov/study/NCT05599581 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/55931
- 30 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluation of the Tu’Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial (Preprint)
BACKGROUND Adolescent girls and young women constitute a priority population disproportionately affected by HIV, accounting for 25% of annual HIV incidence among people older than 15 years in Kenya. Although oral preexposure prophylaxis (PrEP) is effective in reducing HIV acquisition, its protective benefit has been limited among adolescent girls and young women in sub-Saharan Africa because of low uptake, adherence, and persistence. Intimate partner violence (IPV) and relationship power inequities are widespread among adolescent girls and young women and contribute to higher HIV incidence and lower PrEP use. Interventions are needed to support sustained PrEP use among adolescent girls and young women by addressing IPV and relationship dynamics. OBJECTIVE This study aims to test the effectiveness of Tu’Washindi na PrEP (“We are Winners with PrEP”), a multilevel community-based intervention, to increase uptake and adherence to PrEP and reduce IPV among adolescent girls and young women in Siaya County, Kenya. METHODS The Tu’Washindi na PrEP intervention was co-designed by our team and adolescent girls and young women using participatory methods and includes 3 components delivered over 6 months: an 8-session, empowerment-based support club for adolescent girls and young women, community sensitization targeted toward male partners, and PrEP education events for couples. The intervention will be evaluated using a cluster randomized controlled trial across 22 administrative wards in Siaya County, Kenya, enrolling 72 adolescent girls and young women per ward (total N=1584). The primary objectives are to test the effectiveness of the intervention on PrEP uptake and adherence immediately after delivery (month 6 after enrollment) and 6 months later (month 12). As secondary objectives, we will test the intervention effect on IPV. A rigorous process evaluation will explore mechanisms of change, contextual factors, and implementation considerations to inform future refinement and scale-up, using programmatic data, participant questionnaires, and qualitative interviews with participants and intervention providers. RESULTS Data collection started in September 2022. As of December 2024, enrollment has been completed in 16 of the 22 study wards, with 72.6% (1150/1584) of participants enrolled. We anticipate that data collection will be completed in May 2026 and results will be available by mid-2027. CONCLUSIONS The study builds directly on our promising formative and pilot research to develop the evidence base for this youth-designed, multilevel HIV prevention intervention. If effective, Tu’Washindi will be ideally positioned for sustainable integration into existing youth-focused programming to expand and support PrEP use in this priority population. CLINICALTRIAL ClinicalTrials.gov NCT05599581; https://www.clinicaltrials.gov/study/NCT05599581 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/55931
- Open Access
- 16 April 2024
- Published by Taylor & Francis in Global Public Health
- Vol. 19 (1) , 2340500
Outcomes of substance use and sexual power among adolescent girls and young women in Cape Town: Implications for structural and cultural differences
Gender inequality and disparities in population groups are complex phenomena in South Africa. Many communities and neighbourhoods remain largely segregated, with their own racial and ethnic identit...
- 16 April 2024
- Published by Taylor & Francis in Global Public Health
- Vol. 19 (1) , 2340500
Open AccessOutcomes of substance use and sexual power among adolescent girls and young women in Cape Town: Implications for structural and cultural differences
Gender inequality and disparities in population groups are complex phenomena in South Africa. Many communities and neighbourhoods remain largely segregated, with their own racial and ethnic identit...
- Open Access
- 14 October 2022
- Published by Springer Nature in BMC Public Health
- Vol. 22 (1) , 1-11
Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa
Background: Globally, an urgent need exists to expand access to HIV prevention among adolescent girls and young women (AGYW), but the need is particularly acute in sub-Saharan Africa. Oral pre-exposure prophylaxis (PrEP) offers an effective HIV prevention method. In many countries, however, accessing PrEP necessitates that AGYW visit their local health clinic, where they may face access challenges. Some countries have implemented youth-friendly services to reduce certain challenges in local health clinics, but barriers to access persist, including clinic stigma. However, evidence of clinic stigma toward AGYW, particularly with respect to PrEP service delivery, is still limited. This mixed methods study explores stigma toward AGYW seeking clinic services, in particular PrEP, from the perspective of both clinic staff (clinical and nonclinical) and AGYW who seek services at clinic sites in Tshwane province, South Africa. Methods: Six focus group discussions were conducted with AGYW (43 total participants) and four with clinic staff (42 total participants) and triangulated with survey data with AGYW (n = 449) and clinic staff (n = 130). Thematic analysis was applied to the qualitative data and descriptive statistics were conducted with the survey data. Results: Four common themes emerged across the qualitative and quantitative data and with both AGYW and clinic staff, although with varying degrees of resonance between these two groups. These themes included (1) clinic manifestations of stigma toward AGYW, (2) concerns about providing PrEP services for AGYW, (3) healthcare providers’ identity as mothers, and (4) privacy and breaches of confidentiality. An additional theme identified mainly in the AGYW data pertained to stigma and access to healthcare. Conclusion: Evidence is needed to inform strategies for addressing clinic stigma toward AGYW, with the goal of removing barriers to PrEP services for this group. While awareness has increased and progress has been achieved around the provision of comprehensive, youth-friendly sexual and reproductive health services, these programs need to be adapted for the specific concerns of young people seeking PrEP services. Our findings point to the four key areas noted above where programs seeking to address stigma toward AGYW in clinics can tailor their programming.
- 14 October 2022
- Published by Springer Nature in BMC Public Health
- Vol. 22 (1) , 1-11
Open AccessStigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa
Background: Globally, an urgent need exists to expand access to HIV prevention among adolescent girls and young women (AGYW), but the need is particularly acute in sub-Saharan Africa. Oral pre-exposure prophylaxis (PrEP) offers an effective HIV prevention method. In many countries, however, accessing PrEP necessitates that AGYW visit their local health clinic, where they may face access challenges. Some countries have implemented youth-friendly services to reduce certain challenges in local health clinics, but barriers to access persist, including clinic stigma. However, evidence of clinic stigma toward AGYW, particularly with respect to PrEP service delivery, is still limited. This mixed methods study explores stigma toward AGYW seeking clinic services, in particular PrEP, from the perspective of both clinic staff (clinical and nonclinical) and AGYW who seek services at clinic sites in Tshwane province, South Africa. Methods: Six focus group discussions were conducted with AGYW (43 total participants) and four with clinic staff (42 total participants) and triangulated with survey data with AGYW (n = 449) and clinic staff (n = 130). Thematic analysis was applied to the qualitative data and descriptive statistics were conducted with the survey data. Results: Four common themes emerged across the qualitative and quantitative data and with both AGYW and clinic staff, although with varying degrees of resonance between these two groups. These themes included (1) clinic manifestations of stigma toward AGYW, (2) concerns about providing PrEP services for AGYW, (3) healthcare providers’ identity as mothers, and (4) privacy and breaches of confidentiality. An additional theme identified mainly in the AGYW data pertained to stigma and access to healthcare. Conclusion: Evidence is needed to inform strategies for addressing clinic stigma toward AGYW, with the goal of removing barriers to PrEP services for this group. While awareness has increased and progress has been achieved around the provision of comprehensive, youth-friendly sexual and reproductive health services, these programs need to be adapted for the specific concerns of young people seeking PrEP services. Our findings point to the four key areas noted above where programs seeking to address stigma toward AGYW in clinics can tailor their programming.
- Open Access
- 16 July 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (14) , 8661
Gender and Context Matter: Behavioral and Structural Interventions for People Who Use Alcohol and Other Drugs in Africa
Heavy alcohol consumption and other drug use are prominent across Africa and increase the risk of exposure to violence, HIV acquisition, and other life-threatening injuries. This review synthesizes evidence on alcohol and other drug (AOD) interventions in Africa; evaluates the differences between interventions that do and do not specifically target populations that use AODs; and highlights the impact of comprehensive vs. brief interventions and those that address syndemic issues from a gender and contextualized lens. Literature searches were conducted to identify research outcomes of randomized interventions published between January 2010 and May 2022 that address AOD use in Africa. Thirty-five full-text articles were included in this review. Most of the identified research studies were concentrated in a few countries. Most studies were conducted in South Africa. Many of the studies comprised brief interventions. However, the most comprehensive interventions were the most effective for AOD outcomes. Several studies indicated the importance of addressing AOD use alongside gender-based violence, mental health needs, gender roles, and other social determinants that affect health outcomes. Intervening on AOD use and addressing social determinants from a gender and contextually relevant perspective is essential to ensuring the long-term health and well-being of people in Africa.
- 16 July 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (14) , 8661
Open AccessGender and Context Matter: Behavioral and Structural Interventions for People Who Use Alcohol and Other Drugs in Africa
Heavy alcohol consumption and other drug use are prominent across Africa and increase the risk of exposure to violence, HIV acquisition, and other life-threatening injuries. This review synthesizes evidence on alcohol and other drug (AOD) interventions in Africa; evaluates the differences between interventions that do and do not specifically target populations that use AODs; and highlights the impact of comprehensive vs. brief interventions and those that address syndemic issues from a gender and contextualized lens. Literature searches were conducted to identify research outcomes of randomized interventions published between January 2010 and May 2022 that address AOD use in Africa. Thirty-five full-text articles were included in this review. Most of the identified research studies were concentrated in a few countries. Most studies were conducted in South Africa. Many of the studies comprised brief interventions. However, the most comprehensive interventions were the most effective for AOD outcomes. Several studies indicated the importance of addressing AOD use alongside gender-based violence, mental health needs, gender roles, and other social determinants that affect health outcomes. Intervening on AOD use and addressing social determinants from a gender and contextually relevant perspective is essential to ensuring the long-term health and well-being of people in Africa.
- Open Access
- 21 January 2022
- Published by Wiley in Health Expectations
- Vol. 25 (2) , 754-763
‘We have goals but [it is difficult]’. Barriers to antiretroviral therapy adherence among women using alcohol and other drugs living with HIV in South Africa
Background: Women living with HIV who misuse alcohol and live in economically disadvantaged settings in South Africa experience a multitude of contextual barriers as they navigate the HIV care continuum. The Women's Health CoOp (WHC), a brief, woman‐focused, behavioural, evidence‐based intervention, has been shown to be effective in reducing heavy drinking and improving HIV‐related outcomes among this key population. However, these women face other broader socioecological barriers to antiretroviral therapy (ART) adherence.Methods: The WHC was implemented in a modified, stepped‐wedge implementation science trial in public health clinics and substance use treatment programmes in Cape Town, South Africa. A qualitative substudy was conducted to explore barriers to HIV treatment adherence among women enrolled in this trial. Eight focus group discussions were conducted with 69 participants 6 months after completion of the WHC workshops. Focus groups were audio‐recorded (with consent), transcribed verbatim and analysed using a thematic approach.Results: The mean age of the participants was 33 years and the mean self‐reported number of drinks per day was 13. The main contextual factors influencing participants’ ART adherence were intrapersonal‐level factors (substance use, financial constraints, food insecurity; community‐level factors (anticipated and enacted stigma, community violence) and institutional‐level factors (patient–provider relationships, health facility barriers, environmental stigma).Conclusion: Comprehensive interventions addressing the contextual barriers and unique challenges faced by women who misuse alcohol in low‐resource settings that intersect with HIV treatment nonadherence should be implemented in tandem with successful biobehavioural HIV interventions for long‐term effectiveness and sustainability.Patient or Public Contribution: Our South African community collaborative board has been involved throughout this study; participants and clinic staff voices have been essential in our interpretation of these findings.
- 21 January 2022
- Published by Wiley in Health Expectations
- Vol. 25 (2) , 754-763
Open Access‘We have goals but [it is difficult]’. Barriers to antiretroviral therapy adherence among women using alcohol and other drugs living with HIV in South Africa
Background: Women living with HIV who misuse alcohol and live in economically disadvantaged settings in South Africa experience a multitude of contextual barriers as they navigate the HIV care continuum. The Women's Health CoOp (WHC), a brief, woman‐focused, behavioural, evidence‐based intervention, has been shown to be effective in reducing heavy drinking and improving HIV‐related outcomes among this key population. However, these women face other broader socioecological barriers to antiretroviral therapy (ART) adherence.Methods: The WHC was implemented in a modified, stepped‐wedge implementation science trial in public health clinics and substance use treatment programmes in Cape Town, South Africa. A qualitative substudy was conducted to explore barriers to HIV treatment adherence among women enrolled in this trial. Eight focus group discussions were conducted with 69 participants 6 months after completion of the WHC workshops. Focus groups were audio‐recorded (with consent), transcribed verbatim and analysed using a thematic approach.Results: The mean age of the participants was 33 years and the mean self‐reported number of drinks per day was 13. The main contextual factors influencing participants’ ART adherence were intrapersonal‐level factors (substance use, financial constraints, food insecurity; community‐level factors (anticipated and enacted stigma, community violence) and institutional‐level factors (patient–provider relationships, health facility barriers, environmental stigma).Conclusion: Comprehensive interventions addressing the contextual barriers and unique challenges faced by women who misuse alcohol in low‐resource settings that intersect with HIV treatment nonadherence should be implemented in tandem with successful biobehavioural HIV interventions for long‐term effectiveness and sustainability.Patient or Public Contribution: Our South African community collaborative board has been involved throughout this study; participants and clinic staff voices have been essential in our interpretation of these findings.
- Open Access
- 13 July 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7446
Antiretroviral Therapy (ART) Adherence and Prenatal Alcohol Use among Women Who Are Pregnant with HIV in South Africa
This brief report emphasizes the need to focus on women with HIV who are pregnant who use alcohol or other drugs. A recently completed implementation science study tested a gender-focused behavioral intervention, the Women’s Health CoOp (WHC), to improve antiretroviral therapy (ART) adherence and reduce alcohol use among women with HIV. The study identified 33 participants who had a positive pregnancy test result at the baseline assessment, of whom five participants remained pregnant during the 6-month duration of the study. Of the 33 pregnant participants at the baseline assessment, 55% reported past-month alcohol use, with 27% reporting a history of physical abuse and 12% reporting a history of sexual abuse. The five women who remained pregnant at 6 months showed improved ART adherence and reduced prenatal alcohol use. The gender-focused WHC intervention shows promise as a cost-effective, sustainable, behavioral intervention to address these intersecting syndemic issues. Future research should focus on identifying the needs of women with HIV who are pregnant who use alcohol or other drugs and developing tailored evidence-based behavioral interventions such as the WHC for preventing FASD in addition to improving ART adherence in this key population of women and reducing the economic burden on society.
- 13 July 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7446
Open AccessAntiretroviral Therapy (ART) Adherence and Prenatal Alcohol Use among Women Who Are Pregnant with HIV in South Africa
This brief report emphasizes the need to focus on women with HIV who are pregnant who use alcohol or other drugs. A recently completed implementation science study tested a gender-focused behavioral intervention, the Women’s Health CoOp (WHC), to improve antiretroviral therapy (ART) adherence and reduce alcohol use among women with HIV. The study identified 33 participants who had a positive pregnancy test result at the baseline assessment, of whom five participants remained pregnant during the 6-month duration of the study. Of the 33 pregnant participants at the baseline assessment, 55% reported past-month alcohol use, with 27% reporting a history of physical abuse and 12% reporting a history of sexual abuse. The five women who remained pregnant at 6 months showed improved ART adherence and reduced prenatal alcohol use. The gender-focused WHC intervention shows promise as a cost-effective, sustainable, behavioral intervention to address these intersecting syndemic issues. Future research should focus on identifying the needs of women with HIV who are pregnant who use alcohol or other drugs and developing tailored evidence-based behavioral interventions such as the WHC for preventing FASD in addition to improving ART adherence in this key population of women and reducing the economic burden on society.